Trials Designs for Adaptive Interventions –Research Questions Closer to Practice in Trials
Maya Petersen
- Div. Epidemiology & Biostatistics
Trials Designs for Adaptive Interventions Research Questions Closer - - PowerPoint PPT Presentation
Trials Designs for Adaptive Interventions Research Questions Closer to Practice in Trials Maya Petersen Div. Epidemiology & Biostatistics School of Public Health, University of California, Berkeley Precision Public Health
https://www.nih.gov/precision-medicine-initiative-cohort-program
https://www.nih.gov/precision-medicine-initiative-cohort-program
Geng et at, Lancet HIV,
Most patients stay in care with no intervention Reasons for dropout vary
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 180 365 545 730 Days since ART Initiation in care original clinic
died in care died out of care not in care silent transfer
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35
I didn't have enough food I was drinking alcohol I spent too much time at clinic I felt too sick to come to clinic A family member or other… I was experiencing side effects… Medicine was not helpind me… I didn't have enough money to… I was afraid clinic would scold… I didn't want to take drugs… Because I saw/am seeing a… Family conflict prevented… Attending clinic risked… Attending clinic risked… I had family obligations I felt well and I didn't need care Work or need for money… Transportation was too…
Geng et al, CID, 2016
interventions
SMS works best Voucher works best Succeed with SOC Voucher
Voucher Voucher Failure with any intervention Voucher
Review of DTR literature and methods : Dynamic Treatment Regimes in Practice: Planning Trials and Analyzing Data for Personalized Medicine, Moodie E and Kosorok M, eds, 2016.
SMS works best Voucher works best Succeed with SOC SMS
from an intervention get it
Voucher SOC Failure with any intervention SOC
intervention he/she most likely to benefit from
SOC= “Standard of Care”
f i i b i ?
Luedtke & van der Laan 2014; van der Laan and Luedtke 2014;
SMS best Voucher best SOC sufficient
No 1st line works
Navigato r
helped
d
SMS Vouche r Navigator Navigator Voucher
SOC SOC
SMS
SOC
SMS Vouche r Voucher SMS ART start Peer Navigato r
S(0) < θ? Late visit? Late visit? S(1) < θ?
SMS+ Voucher Y N N Y Y N N Y
constraints
– 1st line Voucher for all – 2nd line Navigator for all early failures
See Murphy et al: Many references: https://methodology.psu.edu/ra/adap-inter
NCT02338739; PIs: Geng, Petersen; Site PI Odeny
last time point (assuming future assignment follows
inference (95% CI and p values)
1/3*1/3=1/9
Voucher: 1/3*1/2=1/6
1/3*1=1/3
IPW: Robins & Rotnitzky, 1992; Hernan et al., 2006; TMLE: Bang & Robins, 2005; van der Laan & Gruber 2012
MSM: Robins, 1999; Dynamic MSM: Petersen & van der Laan, 2007
E(Y(θ)|V)=expit(β0 + β1θ + β2θ2 + β3V + β4θV)
Zhang et al., 2013
Robins, 1999; Petersen & van der Laan, 2007; Schnitzer et. al., 2013; Petersen et. al 2014
0.5 0.55 0.6 0.65 0.7 0.75 0.8 0.85 0.9 0.95 1 Variance Relative to IPW: known wts. IPW: known wts. IPW: est. wt. TMLE θopt(V)=α0+α1V
All Estimators: good/conservative 95% CI coverage and Type I error control
Petersen et al. Ch 10 In: Moodie & Kosorok, Dynamic Treatment Regimes in Practice 2016
– Petersen et. al. Ch 10. In: Dynamic Treatment Regimes in Practice, Moodie E and Kosorok M, editors 2016
– Causal effect estimation with multiple intervention nodes
– General longitudinal data structures
– Estimators
formulas or calling SuperLearner()
http://cran.r-project.org/web/packages/ltmle/; Schwab et al 2013
1.
2. M A Hernan, E Lanoy, D Costagliola, and J M Robins. Comparison of dynamic treatment regimes via inverse probability weighting. Basic & Clinical Pharmacology & Toxicology, 98:237242, 2006. 3. M Petersen, J. Schwab, E Geng, and M van der Laan. Evaluation of longitudinal dynamic regimes with and without marginal structural working models. In Moodie E and Kosorok M, editors, Dynamic Treatment Regimes in Practice: Planning Trials and Analyzing Data for Personalized Medicine., chapter 10, pp. 157-186. ASA-SIAM, 2016. 4. M.L. Petersen, J. Schwab, S. Gruber, N. Blaser, M. Schomaker, and M. van der Laan. Targeted maximum likelihood estimation for dynamic and static marginal structural working models. Journal of Causal Inference, 2(2), 2014. 5.
using surrogate markers. In AIDS Epidemiology, pp: 297-331. Springer, 1992. 6. J.M. Robins. Marginal Structural Models versus Structural Nested Models as Tools for Causal Inference, volume 116 of IMA, pages 95-134. Springer, New York, NY, 1999. 7. J.M. Robins. Robust estimation in sequentially ignorable missing data and causal inference
1999, pages 6-10, 2000. 8. M.E. Schnitzer, Erica E.M. Moodie, and Robert W. Platt. Targeted maximum likelihood estimation for marginal time-dependent treatment effects under density misspecication. Biostatistics, 14(1):1{14, 2013. 9. M J Van der Laan and M L Petersen. Causal eect models for realistic individualized treatment and intention to treat rules. The International Journal of Biostatistics, 3, 2007.
multiple time point interventions. The International Journal of Biostatistics, 8(1):Article 8, 2012.
ti l d i t t t i f ti l t t t d i i Bi t ik 100(3) 681